Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study-Reference-Cited by-同舟云学术

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study

Published:2018-12 Issue: Volume:206 Page:80-93
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Pradhan Aruna D.,Paynter Nina P.,Everett Brendan M.,Glynn Robert J.,Amarenco Pierre,Elam Marshall,Ginsberg Henry,Hiatt William R.,Ishibashi Shun,Koenig Wolfgang,Nordestgaard Børge G.,Fruchart Jean-Charles,Libby Peter,Ridker Paul M

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference87 articles.

1. Diabetic dyslipidaemia: from basic research to clinical practice;Taskinen;Diabetologia,2003

2. Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies;Chan;Expert Opin Pharmacother,2011

3. Special Populations: Diabetes and Metabolic Syndrome;Reyes-Soffer,2014

4. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias;Catapano;Eur Heart J,2016

5. Are elevated serum triglycerides really a risk factor for coronary artery disease?;Reiner;Cardiology,2015

Cited by 272 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lessons from PROMINENT and prospects for pemafibrate;Cardiovascular Diabetology;2024-07-29

2. New Insights Into the Treatment of Hyperlipidemia: Pharmacological Updates and Emerging Treatments;Cureus;2024-06-24

3. Current trends in solving the problem of residual cardiovascular risk;Meditsinskiy sovet = Medical Council;2024-05-19

4. The latest emerging drugs for the treatment of diabetic cardiomyopathy;Expert Opinion on Pharmacotherapy;2024-04-12

5. A Practical Approach to the Management of Residual Cardiovascular Risk: United Arab Emirates Expert Consensus Panel on the Evidence for Icosapent Ethyl and Omega-3 Fatty Acids;Cardiovascular Drugs and Therapy;2024-02-16